Sec Form 4 Filing - Baird Melissa @ Hims & Hers Health, Inc. - 2021-01-20

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Baird Melissa 2. Issuer Name and Ticker or Trading Symbol Hims & Hers Health, Inc. [ HIMS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Operating Officer (Last) (First) (Middle) 2269 CHESTNUT STREET, #523 3. Date of Earliest Transaction (MM/DD/YY) 01/20/2021 (Street) SAN FRANCISCO, CA94123 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 01/20/2021 A 99,458 A 99,458 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant (right to buy) $ 11.5 01/20/2021 A 556 ( 3 ) 01/20/2026 Class A Common Stock 556 $ 0 556 D Stock Option (right to buy) $ 0.4 01/20/2021 A 161,059 ( 4 ) 03/28/2028 Class A Common Stock 161,059 $ 0 161,059 D Stock Option (right to buy) $ 0.4 01/20/2021 A 925,664 ( 5 ) 03/28/2028 Class A Common Stock 925,664 $ 0 925,664 D Stock Option (right to buy) $ 1.75 01/20/2021 A 113,245 ( 6 ) 11/05/2029 Class A Common Stock 113,245 $ 0 113,245 D Stock Option (right to buy) $ 2.43 01/20/2021 A 779,073 ( 7 ) 05/12/2030 Class A Common Stock 779,073 $ 0 779,073 D Stock Option (right to buy) $ 9.41 01/20/2021 A 265,899 ( 8 ) 12/22/2030 Class A Common Stock 265,899 $ 0 265,899 D Restricted Stock Unit ( 9 ) 01/20/2021 A 132,723 ( 10 ) ( 10 ) Class A Common Stock 132,723 $ 0 132,723 D Restricted Stock Unit ( 11 ) 01/20/2021 A 12,983 ( 12 ) ( 12 ) Class A Common Stock 12,983 $ 0 12,983 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Baird Melissa 2269 CHESTNUT STREET, #523 SAN FRANCISCO, CA94123 Chief Operating Officer Signatures /s/ Soleil Boughton, Attorney-in-Fact 01/22/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 90,596 shares of Class A Common Stock of New Hims and (ii) 8,862 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 200,000 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited. ( 2 )(Continued from footnote 1)On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share. ( 3 )In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in partial exchange for shares of Class A Common Stock of Hims, Inc. ( 4 )The Stock Option was received in exchange for an option to purchase 355,555 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.18, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning February 6, 2018. ( 5 )The Stock Option was received in exchange for an option to purchase 2,043,499 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.18, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning February 6, 2018. ( 6 )The Stock Option was received in exchange for an option to purchase 250,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.79, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning October 1, 2019. ( 7 )The Stock Option was received in exchange for an option to purchase 1,719,884 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement). ( 8 )The Stock Option was received in exchange for an option to purchase 587,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $4.26, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning December 16, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement). ( 9 )In connection with the Merger, th e Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs"). ( 10 )The New Hims RSUs were received in exchange for 293,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service. The New Hims RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). The New Hims RSU expires in December 2027. ( 11 )In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs"). ( 12 )The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 10 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.